Nonadherence to antipsychotic medication is highly prevalent in patients with schizophrenia and leads to unfavourable outcomes, such as a five-fold risk of hospitalisation, elevated risks for suicide and aggresive incidents and increased overall costs. The causes of nonadherence are diverse and consist of obvious factors such as medication side effects and unawareness of illness. Emile Barkhof reviews the effects of existing interventions to improve adherence rates and examines in more detail the effects of a specific intervention, Motivational Interviewing (MI), on treatment adherence and its consequences in patients with schizophrenia.
E. Barkhof, Motivation for Adherence to Treatment in Chronic Psychotic Disorders: Intervention Strategies and Social Cognitive Factors.
Prof. L. de Haan
Dr C.J. Meijer
Dr L.M.J. Sonneville
This event is open to the public.